Urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Urges Japan to honor its commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals by: (1) reducing regulatory barriers to the approval and adoption of new medical technologies; (2) meeting or exceeding agency performance goals for premarket approvals and adopting an appropriate, risk-based postmarket system consistent with globally accepted practices; (3) promoting pricing policies that encourage innovation and eliminating reimbursement policies based on inappropriate comparisons to markets outside Japan; (4) implementing fair and open processes and rules that do not disproportionately harm U.S. medical technology products; and (5) providing opportunities for consultation with trading partners.
Referred to the House Committee on Ways and Means.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H. Con. Res. 311: Urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, and for other purposes.. 109th Congress. Open America. https://openamerica.io/bill/109-HCONRES-311/
"H. Con. Res. 311: Urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, and for other purposes.." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HCONRES-311/.
H. Con. Res. 311, 109th Cong. (2026), https://openamerica.io/bill/109-HCONRES-311/.
[H. Con. Res. 311: Urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, and for other purposes.](https://openamerica.io/bill/109-HCONRES-311/)